Article Details
Retrieved on: 2018-03-30 20:11:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Exane Derivatives decreased its stake in <b>Cme Group</b> (CME) by 11.98% based on its latest 2017Q4 regulatory filing with the SEC. Exane Derivatives sold 627 shares as the company's stock rose 9.29% while stock markets declined. The institutional investor held 4,608 shares of the investment bankers ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here